GSK's recently-unveiled plan to develop a bioscience cluster close to its main R&D site in Stevenage, UK, has moved closer to fruition, now that the first partners have joined the initiative. The ...

Stevenage is already one of GSK's two global research and development hubs, and hosts the UK's largest work into cell and gene therapy. The development of the new site is expected to begin in 2022.

GSK is currently searching for a development partner through which it can sell 13.3 hectares of its plot in Stevenage. The company hopes that the sale will unlock £400m in investment from a ...

GlaxoSmithKline wants to sell more than a third of the space at its R&D campus in Stevenage, UK, to a new bioscience cluster that it says could become one of the largest in Europe. The drugmaker ...

GSK has today announced that it has formally started the process of seeking a development partner to transform land within the company’s existing 92-acre Research & Development site in Stevenage into ...

Stevenage is already home to a world-leading life science cluster, including more than 40 life science companies and the Cell and Gene Therapy Catapult. The vision for the new campus was developed in ...

Drug and pharmaceuticals giant GSK is set to create up to 5,000 new jobs over the next ten years as part of plans to create one of Europe’s largest biotechnology campuses in Hertfordshire ...

(RTTNews) - Drugs giant GlaxoSmithKline plc (GSK, GSK.L) announced a new development plan that will create up to 5,000 new jobs over the next decade. GSK said it has formally started the process ...

GlaxoSmithKline aims to sell almost one-third of its 370,000 m 2 R&D site in Stevenage, England, so that the land can be transformed into a biotech science campus. GSK says the plan could unlock ...

Britain's GlaxoSmithKline on Friday laid out plans to set up a new life sciences campus within its R&D site in Stevenage, England, raising up to 400 million pounds ($552.76 million) by selling ...

"NICE approves GSK’s belantamab mafodotin for blood cancer" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this ...

GSK to build £400m hub in Stevenage - creating 5,000 jobs "The past 18 months has shown the UK life sciences sector at its best," a senior GSK executive said in a statement. Friday 16 July 2021 ...